Literature DB >> 26115166

Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways.

Jessica J Ciomperlik1, Holly A Basta2, Ann C Palmenberg3.   

Abstract

Cardiovirus infections inhibit nucleocytoplasmic trafficking by Leader protein-induced phosphorylation of Phe/Gly-containing nucleoporins (Nups). Recombinant Leader from encephalomyocarditis virus, Theiler׳s murine encephalomyelitis virus and Saffold virus target the same subset of Nups, including Nup62 and Nup98, but not Nup50. Reporter cell lines with fluorescence mCherry markers for M9, RS and classical SV40 import pathways, as well as the Crm1-mediated export pathway, all responded to transfection with the full panel of Leader proteins, showing consequent cessation of path-specific active import/export. For this to happen, the Nups had to be presented in the context of intact nuclear pores and exposed to cytoplasmic extracts. The Leader phosphorylation cascade was not effective against recombinant Nup proteins. The findings support a model of Leader-dependent Nup phosphorylation with the purpose of disrupting Nup-transportin interactions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovirus; Leader protein; Nucleocytoplasmic trafficking inhibition; Okadaic acid

Mesh:

Substances:

Year:  2015        PMID: 26115166      PMCID: PMC4567469          DOI: 10.1016/j.virol.2015.06.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  The Leader Protein of Theiler's Virus Prevents the Activation of PKR.

Authors:  Fabian Borghese; Frédéric Sorgeloos; Teresa Cesaro; Thomas Michiels
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.

Authors:  Kelly Watters; Bahar Inankur; Jaye C Gardiner; Jay Warrick; Nathan M Sherer; John Yin; Ann C Palmenberg
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  Cardiovirus Leader proteins bind exportins: Implications for virus replication and nucleocytoplasmic trafficking inhibition.

Authors:  Jessica J Ciomperlik; Holly A Basta; Ann C Palmenberg
Journal:  Virology       Date:  2015-10-19       Impact factor: 3.616

4.  Intracellular localization of Saffold virus Leader (L) protein differs in Vero and HEp-2 cells.

Authors:  Yishi Xu; Carla Bianca Luena Victorio; Qimei Ng; Mookkan Prabakaran; Yee-Joo Tan; Kaw Bing Chua
Journal:  Emerg Microbes Infect       Date:  2016-10-12       Impact factor: 7.163

Review 5.  Protein phosphatases at the nuclear envelope.

Authors:  Raquel Sales Gil; Ines J de Castro; Jerusalem Berihun; Paola Vagnarelli
Journal:  Biochem Soc Trans       Date:  2018-02-06       Impact factor: 5.407

6.  TDP-43 proteinopathy in Theiler's murine encephalomyelitis virus infection.

Authors:  Katsuhisa Masaki; Yoshifumi Sonobe; Ghanashyam Ghadge; Peter Pytel; Raymond P Roos
Journal:  PLoS Pathog       Date:  2019-02-11       Impact factor: 6.823

Review 7.  Saffold virus, an emerging human cardiovirus.

Authors:  Shawn Zheng Kai Tan; Mark Zheng Yi Tan; Mookkan Prabakaran
Journal:  Rev Med Virol       Date:  2016-10-10       Impact factor: 6.989

Review 8.  Innate Immune Detection of Cardioviruses and Viral Disruption of Interferon Signaling.

Authors:  Eric C Freundt; Melissa Drappier; Thomas Michiels
Journal:  Front Microbiol       Date:  2018-10-12       Impact factor: 5.640

9.  The Effect of FG-Nup Phosphorylation on NPC Selectivity: A One-Bead-Per-Amino-Acid Molecular Dynamics Study.

Authors:  Ankur Mishra; Wouter Sipma; Liesbeth M Veenhoff; Erik Van der Giessen; Patrick R Onck
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

10.  Characterization of Plaque-Sized Variants of Daniel's (DA) Strain in Theiler's Virus-Induced Epilepsy.

Authors:  M Bijalwan; C R Young; J Tingling; X J Zhou; A R Rimmelin; J L Leibowitz; C J Welsh
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.